Insmed IncorporatedINSMNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank95
Year-over-Year Change
Year-over-year operating income growth rate
Latest
31.77%
↑ 450% vs avg
Percentile
P95
Near historical high
Streak
2 qtr
Consecutive growthAccelerating
Average
-9.08%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 31.77% |
| Q3 2025 | -16.98% |
| Q2 2025 | -26.09% |
| Q1 2025 | -7.69% |
| Q4 2024 | -7.96% |
| Q3 2024 | 26.12% |
| Q2 2024 | -98.55% |
| Q1 2024 | 18.38% |
| Q4 2023 | -20.72% |
| Q3 2023 | 37.30% |
| Q2 2023 | -58.97% |
| Q1 2023 | 2.19% |
| Q4 2022 | -18.62% |
| Q3 2022 | -44.59% |
| Q2 2022 | 1.69% |
| Q1 2022 | 9.33% |
| Q4 2021 | 4.38% |
| Q3 2021 | -16.99% |
| Q2 2021 | -5.65% |
| Q1 2021 | 11.32% |
| Q4 2020 | -68.15% |
| Q3 2020 | -3.90% |
| Q2 2020 | 10.34% |
| Q1 2020 | -28.20% |
| Q4 2019 | 16.65% |
| Q3 2019 | 9.13% |
| Q2 2019 | 10.56% |
| Q1 2019 | 20.76% |
| Q4 2018 | -4.45% |
| Q3 2018 | -15.23% |
| Q2 2018 | -16.14% |
| Q1 2018 | 3.98% |
| Q4 2017 | -48.25% |
| Q3 2017 | -1.31% |
| Q2 2017 | -20.98% |
| Q1 2017 | 46.36% |
| Q4 2016 | -80.49% |
| Q3 2016 | -2.81% |
| Q2 2016 | -9.27% |
| Q1 2016 | -1.46% |